Free Trial

Addus HomeCare (NASDAQ:ADUS) Upgraded to "Buy" at Wall Street Zen

Addus HomeCare logo with Medical background

Addus HomeCare (NASDAQ:ADUS - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Sunday.

ADUS has been the topic of several other reports. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Friday, June 20th. Stephens reissued an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, Macquarie reissued an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $142.57.

Check Out Our Latest Stock Report on Addus HomeCare

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $2.31 during mid-day trading on Friday, reaching $110.64. The company's stock had a trading volume of 72,522 shares, compared to its average volume of 165,892. The stock has a market capitalization of $2.04 billion, a P/E ratio of 24.99, a P/E/G ratio of 1.63 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72. The stock has a 50-day moving average of $110.90 and a two-hundred day moving average of $111.53.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same quarter last year, the firm earned $1.21 EPS. The business's revenue was up 20.3% compared to the same quarter last year. On average, equities research analysts anticipate that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at approximately $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 4.60% of the company's stock.

Hedge Funds Weigh In On Addus HomeCare

A number of large investors have recently bought and sold shares of the company. New York State Common Retirement Fund raised its holdings in Addus HomeCare by 6.0% during the fourth quarter. New York State Common Retirement Fund now owns 14,098 shares of the company's stock worth $1,767,000 after purchasing an additional 800 shares in the last quarter. Handelsbanken Fonder AB raised its stake in shares of Addus HomeCare by 17.2% during the 4th quarter. Handelsbanken Fonder AB now owns 4,083 shares of the company's stock worth $512,000 after buying an additional 600 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $258,000. Illinois Municipal Retirement Fund boosted its stake in shares of Addus HomeCare by 2.4% in the fourth quarter. Illinois Municipal Retirement Fund now owns 9,657 shares of the company's stock valued at $1,211,000 after buying an additional 223 shares in the last quarter. Finally, Oppenheimer & Co. Inc. grew its holdings in Addus HomeCare by 21.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 6,038 shares of the company's stock worth $757,000 after acquiring an additional 1,047 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines